The Medicis Pharma CEO And A Dead Girlfriend
There may be an honest-to-goodness whodunnit unfolding at Medicis Pharmaceutical, where the nude body of the 32-year-old, live-in girlfriend of Jonah Shacknai, who runs the drugmaker, was found yesterday at his seaside home in Coronado, California. She has since been identified as Rebecca Nalepa and his brother found her hanging by her neck from a […]
Read More »Category : News
FDA warns mesh used in surgery poses risk
Women who have vaginal surgery to fix a common gynecologic condition called pelvic organ prolapse may wind up with more problems than benefits if a plastic mesh is used, according to a safety communication issued yesterday by the Food and Drug Administration. The agency warned patients and surgeons to consider other options. The FDA said […]
Read More »Category : News
Merck Job Cuts To Pick Up Steam
Source: Pharmalot.com Last year, Merck disclosed plans to save up to $3.5 billion by closing numerous research sites and manufacturing plants, and eliminate roughly 15,000 jobs by 2012, or roughly 10 percent of the total headcount that included the thousands of people who were part of the 2009 acquisition of Schering-Plough. Before the deal, Merck […]
Read More »Category : News
Elan Eliminates More Than 100 Jobs
Source: Pharmalot.com Following the recent decision to sell its drug manufacturing unit to Alkermes for $960 million, Elan is eliminating 104 jobs from a Pennsylvania facility that is part of the deal, according to a notice filed with the Pennsylvania Department of Labor . The jobs will be gone next month and the facility is […]
Read More »Category : News
Cadila to see marginal impact of USFDA warning letter
Cadila Healthcare recently received a warning letter from the US Food and Drug Administration (USFDA) with regard to the company’s Gujarat plant. Cadila is said to have violated the current good manufacturing practice (CGMP) regulations for finished pharmaceuticals at its facility in Gujarat. Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that since […]
Read More »Category : News
J&J Faces Misdemeanor For Natrecor Marketing
Source: Pharmalot.com Federal prosecutors have charged the Johnson & Johnson Scios unit with mislabeling the acute heart failure drug Natrecor. In a filing in federal court in California, the feds say labeling “lacked adequate directions for use†between 2001 and 2005. J&J was charged with a single misdemeanor and faces a fine of $200,000, or […]
Read More »Category : News
Pharma Execs Confess Innovation Is Lacking
Source: Pharmalot.com When the going gets tough, do the tough know now to innovate? Apparently not. At least that’s what a bunch of pharma execs confess in a new survey that finds only 54 percent – including those who admit to having poor or ineffective innovation strategies – consider innovation to be a leading priority. […]
Read More »Category : News
Alzheimer’s Clinical Trial Rules Are Loosened
Source: Pharmalot.com A group of academic and industry experts has convinced the FDA to ease safety restrictions on clinical trials for Alzheimer’s drugs, which were imposed after a 2008 study of a developing med found cases of a brain-swelling condition known as vasogenic edema. That undermined confidence in the safety of drugs focusing on reducing […]
Read More »Category : News
Pfizer, J&J’s Alzheimer’s Drugs To Get Boost from FDA Trial Rules
There are no good drugs yet for treating Alzheimer’s disease, which is notoriously complex and poses many challenges to developers. Yet with the nudging of industry and academics, the FDA has loosened some safety restrictions on trials for amyloid-lowering drugs against the disease, making it that much easier for companies like Pfizer, J&J and Eli […]
Read More »Category : News
Takeda Pulls Actos In France Over Bladder Cancer
Source: Pharmalot.com One month after French regulators suspended the use of the Actos diabetes pill after a review of pharmacovigilance data showed an increased risk of bladder cancer, Takeda Pharmaceuticals has withdrawn the drug. The Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) also asked Takeda to withdraw a related brand called Competact. […]
Read More »Category : News
